Mutational analysis revealed that HAS displayed a frequent mutational spectrum containing a list of cancer-related genes compared with non-HAS and TCGA-LIHC, such as TP53, PCLO, and BRCA2. The enrichment of TP53 mutation was considered as a key genomic feature in previous studies. The gene discussed is BRCA2; the disease is cancer.